Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CLEAR trial of hypertonic saline and carbocisteine in bronchiectasis
2017-000664-14Phase 3Unknown
- Sponsor
- Belfast Health and Social Care Trust
- Start
- Oct 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, single-blind trial of hypertonic saline and carbocisteine in bronchiectasis (4 arms), sponsored by Belfast Health and Social Care Trust. Primary endpoint: Number of exacerbations over 52 weeks post-randomization. Status: unknown.
02
Drugs
hypertonic salinecarbocisteine
03
Conditions
bronchiectasis
Beyond the preview
Go deeper on 2017-000664-14.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2017-000664-14.